Suchergebnisse - "Chappell, James D"

PubPharm (7)

1

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

enthalten in: The Journal of clinical investigation | 2022

von Linderman, S. | Lai, L. | Bocangel Gamarra, E. | +19

CommentIn: J Clin Invest. 2022 Dec 1;132(23):. - PMID 36453549

2

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

enthalten in: The New England journal of medicine | 2021

von Widge, A. | Rouphael, N. | Jackson, L. | +129

3

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

enthalten in: The New England journal of medicine | 2020

von Anderson, E. | Rouphael, N. | Widge, A. | +135

CommentIn: Tidsskr Nor Laegeforen. 2021 Nov 15;141(18):. - PMID 34911279

4

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

enthalten in: The New England journal of medicine | 2020

von Jackson, L. | Anderson, E. | Rouphael, N. | +131

CommentIn: N Engl J Med. 2020 Nov 12;383(20):1986-1988. - PMID 32663910

5

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

enthalten in: Nature | 2020

von Corbett, K. | Edwards, D. | Leist, S. | +59

UpdateOf: bioRxiv. 2020 Jun 11;:. - PMID 32577634

6

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

enthalten in: Journal of virology | 2018

von Wang, L. | Shi, W. | Chappell, J. | +23

7

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2017

von Pallesen, J. | Wang, N. | Corbett, K. | +15

1
[1]